Twitter LinkedIn
    Thursday, August 18
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»Perrigo to sell generic drugs business for $1.55 billion
    Deals

    Perrigo to sell generic drugs business for $1.55 billion

    March 2, 2021Updated:March 2, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Perrigo Company Plc on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business.

    The sale, to private equity firm Altaris Capital Partners, is expected to close by the end of the third quarter, Perrigo said.

    “After the transaction closes, Perrigo expects to have more than $2 billion in cash available to advance its consumer self-care strategy, preferably through prudent and revenue accretive M&A,” Chief Executive Officer Murray Kessler said.

    Lower sales of Perrigo’s cold and cough products drove it to a net loss of $162.6 million in the fourth quarter versus a $146.1 million profit last year.

    Read More

    Source: Reuters

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Deal PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Saudi Arabia’s PIF, Cain invest $900m in hotelier Aman Group

    August 17, 2022

    Denham Capital to sell Nexif Energy’s portfolio to RATCH Group in deal worth $1B

    August 17, 2022

    Thompson Street Capital Partners closes sixth PE fund at over $1.5B in commitments

    August 17, 2022

    KKR acquires Barracuda from Thoma Bravo

    August 17, 2022

    Comments are closed.

    Other Articles

    Inovia Capital closes second growth-stage fund at USD450m

    March 18, 2021

    KKR, BlackRock get approval to invest in Chinese funds overseas

    May 10, 2022

    Carlyle acquires German distribution logistics assets

    January 9, 2021

    Nuventura raises new funding to support global expansion of SF6-free gas insulated switchgear

    March 17, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?